Paradoxical cancer cell proliferation after FGFR inhibition through decreased p21 signaling in FGFR1-amplified breast cancer cells is a research paper published in Breast Cancer Research (2024). On theSindex it has a DataRank of 0.360. It has been cited 10 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.360
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute of the National Institutes of Health
Grant: U01CA264620 (AHB)
NCI NIH HHS
Grant: U54 CA209978
NCI NIH HHS
Grant: U01 CA264620
National Institutes of Health
Grant: 5U54CA209978-06
Combating Subclonal Evolution of Resistant Cancer Phenotypes
National Institutes of Health
Grant: 3U01CA264620-02S1
AKT as a resistance mechanism to cell cycle and endocrine therapies in ER+ breast cancer
FWCI
1.57
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals